These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446). Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764 [TBL] [Abstract][Full Text] [Related]
4. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats. Komori T; Takada T; Funae Y; Yamamoto K Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787 [No Abstract] [Full Text] [Related]
5. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril. Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298 [TBL] [Abstract][Full Text] [Related]
6. [High-performance liquid chromatography of organosulfur compounds using the postcolumn ligand exchange reaction with iodoplatinate. Application to the simultaneous determination of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidine carboxylic acid (SA446), an angiotensin converting enzyme inhibitor and its urinary metabolites]. Horiuchi M; Takashina H; Fujimura K; Iso T Yakugaku Zasshi; 1986 Nov; 106(11):1028-33. PubMed ID: 3031265 [No Abstract] [Full Text] [Related]
7. Species difference of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinec arb oxylic acid (SA446) in inhibition of angiotensin converting enzyme. Nakata K; Iwatani T; Horiuchi M; Kito H; Yamauchi H; Iso T Jpn J Pharmacol; 1986 Mar; 40(3):367-72. PubMed ID: 3012163 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421. Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563 [No Abstract] [Full Text] [Related]
9. Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446. Mendelsohn FA; Csicsmann J; Hutchinson JS Clin Sci (Lond); 1981 Dec; 61 Suppl 7():277s-280s. PubMed ID: 6172236 [TBL] [Abstract][Full Text] [Related]
10. Determination of a new antihypertensive agent (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid in blood by high-performance liquid chromatography with electrochemical detection. Shimada K; Tanaka M; Nambara T; Imai Y J Pharm Sci; 1984 Jan; 73(1):119-21. PubMed ID: 6694067 [TBL] [Abstract][Full Text] [Related]
11. Reproductive toxicity studies of rentiapril. Cozens DD; Barton SJ; Clark R; Hughes EW; Offer JM; Yamamoto Y Arzneimittelforschung; 1987 Feb; 37(2):164-9. PubMed ID: 3034299 [TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin I-converting enzyme inhibitor (SA-446) on renal function in dogs. Takada T; Yamamoto K; Fujioka S; Tamaki T; Fukui K; Abe Y Jpn J Pharmacol; 1985 Jun; 38(2):227-30. PubMed ID: 2993720 [TBL] [Abstract][Full Text] [Related]
13. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension]. Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607 [No Abstract] [Full Text] [Related]
14. [Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine]. Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Krit NA; Filatova MP Vopr Med Khim; 1984; 30(3):51-6. PubMed ID: 6206649 [TBL] [Abstract][Full Text] [Related]
15. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats. Komori T; Yamamoto K Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629 [TBL] [Abstract][Full Text] [Related]
16. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme. DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478 [TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats. Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170 [TBL] [Abstract][Full Text] [Related]
18. [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration]. Takada T; Nakata K; Yamauchi H; Iso T Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):331-7. PubMed ID: 3710315 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine. Saruta T; Suzuki H; Okuno T; Kondo K Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110 [TBL] [Abstract][Full Text] [Related]
20. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats. Takata Y; Di Nicolantonio R; Hutchinson JS Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]